Royalty Pharma (RPRX) News Today $24.92 +0.64 (+2.64%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Wellington Management Group LLP Sells 39,598 Shares of Royalty Pharma plc (NASDAQ:RPRX)Wellington Management Group LLP lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 69.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,806 shares of the biopharmaceuticDecember 21 at 3:41 AM | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Bought by Franklin Resources Inc.Franklin Resources Inc. boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,460,515 shares of the biopharmaceutical comDecember 18 at 4:55 AM | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of "Moderate Buy" by AnalystsRoyalty Pharma plc (NASDAQ:RPRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the comDecember 18 at 4:26 AM | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Barclays PLCBarclays PLC increased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 16.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 308,887 shares of the biopharmaceutical company's stock after acquirDecember 18 at 4:07 AM | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low - What's Next?Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month Low - Time to Sell?December 17, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Geode Capital Management LLCGeode Capital Management LLC raised its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,265,786 shares of the biopharmaceutical company's stocDecember 16, 2024 | marketbeat.comSynovus Financial Corp Trims Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Synovus Financial Corp lessened its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 53.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 104,297 shares of the biopharmaceutical company's stock after selDecember 15, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Stock, Insider Trading ActivityDecember 14, 2024 | benzinga.com3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or LongerDecember 13, 2024 | fool.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by State Street CorpState Street Corp grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 0.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,516,262 shares of the biopharmDecember 11, 2024 | marketbeat.comExecutive Wealth Management LLC Has $2.11 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Executive Wealth Management LLC trimmed its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 23.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,700 shares of the biopharmaceutical company's stock after seDecember 10, 2024 | marketbeat.comKovitz Investment Group Partners LLC Decreases Stake in Royalty Pharma plc (NASDAQ:RPRX)Kovitz Investment Group Partners LLC reduced its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 29.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 118,75December 9, 2024 | marketbeat.com526,633 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 526,633 shares of the biopharmaceutical company's stock, valued at approDecember 7, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Sells 127,825 Shares of Royalty Pharma plc (NASDAQ:RPRX)The Manufacturers Life Insurance Company decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 45.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 152,027 shares of the biopharmaceutical company's stock after sellDecember 7, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Two Sigma Advisers LPTwo Sigma Advisers LP boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 44.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,033,200 shares of the biopharmaceutical company's stock aDecember 6, 2024 | marketbeat.comPoint72 DIFC Ltd Invests $1.86 Million in Royalty Pharma plc (NASDAQ:RPRX)Point72 DIFC Ltd bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 65,861 shares of the biopharmaceutical company's stock, valued at approximately $1,863,000. Several other institutionalDecember 5, 2024 | marketbeat.comIs Royalty Pharma (RPRX) the Best All-Time Low Stock to Buy Right Now?December 4, 2024 | insidermonkey.com2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the DipsDecember 4, 2024 | fool.comArrowMark Colorado Holdings LLC Makes New $2.03 Million Investment in Royalty Pharma plc (NASDAQ:RPRX)ArrowMark Colorado Holdings LLC bought a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 71,750 shares of the biopharmaceutical company's sDecember 3, 2024 | marketbeat.comPDT Partners LLC Sells 20,502 Shares of Royalty Pharma plc (NASDAQ:RPRX)PDT Partners LLC reduced its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 39.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,934 shares of the biopharmaceutical company's stock afterDecember 3, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,972,201 shares ofDecember 3, 2024 | marketbeat.com3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or LongerDecember 3, 2024 | fool.comGlenmede Trust Co. NA Sells 198,419 Shares of Royalty Pharma plc (NASDAQ:RPRX)Glenmede Trust Co. NA lessened its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 80.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,579 shares of the biopharmaceutical company's stock after selling 198,419December 2, 2024 | marketbeat.comBank of Montreal Can Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Bank of Montreal Can increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 186.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 445,937 shares of the biopharmaceutical company's stock after purchasingDecember 2, 2024 | marketbeat.comD.A. Davidson & CO. Purchases New Shares in Royalty Pharma plc (NASDAQ:RPRX)D.A. Davidson & CO. acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 45,965 shares of the biopharmaceutical company's stock, valuedDecember 1, 2024 | marketbeat.comEventide Asset Management LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Eventide Asset Management LLC boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 3.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 772,623 shares of the biopharmaceutNovember 29, 2024 | marketbeat.comCitigroup Inc. Sells 66,237 Shares of Royalty Pharma plc (NASDAQ:RPRX)Citigroup Inc. lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 11.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 528,502 shares of the biopharmaceuticalNovember 28, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $84.92 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Charles Schwab Investment Management Inc. increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 58.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,001,603 shares of the biopharmacNovember 28, 2024 | marketbeat.comRoyalty Pharma to Present at Upcoming Investor ConferencesNovember 27, 2024 | globenewswire.comDai ichi Life Insurance Company Ltd Has $4.79 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)Dai ichi Life Insurance Company Ltd grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 79.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 169,270 shares of the biopharmaceutical company's stNovember 27, 2024 | marketbeat.com39,493 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by Qsemble Capital Management LPQsemble Capital Management LP bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm bought 39,493 shares of the biopharmaceutical company's stock, valued at approximately $1,117,000. SeveNovember 27, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Raises Position in Royalty Pharma plc (NASDAQ:RPRX)BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 58.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 634,501 shares of thNovember 23, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six ratings firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have givNovember 23, 2024 | marketbeat.comThrivent Financial for Lutherans Purchases 168,905 Shares of Royalty Pharma plc (NASDAQ:RPRX)Thrivent Financial for Lutherans lifted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 96.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 343,150 shares of the biopharmaceuticNovember 22, 2024 | marketbeat.comOverbrook Management Corp Decreases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Overbrook Management Corp trimmed its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 29.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,908 shares of the biopharmaceuNovember 21, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading Volume - What's Next?Royalty Pharma (NASDAQ:RPRX) Sees Large Volume Increase - Still a Buy?November 19, 2024 | marketbeat.comStrong Buy Rating for Royalty Pharma: Robust Revenue Growth and Promising PipelineNovember 19, 2024 | markets.businessinsider.comRoyalty Pharma price target raised to $39 from $38 at BofANovember 19, 2024 | markets.businessinsider.comVictory Capital Management Inc. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Victory Capital Management Inc. lifted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 26.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 849,035 shares of the biopharmaceutical company's sNovember 19, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stake Reduced by Amalgamated BankAmalgamated Bank decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 70.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,469 shares of the biopharmaceutical cNovember 17, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low - Time to Sell?Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year Low - Here's What HappenedNovember 15, 2024 | marketbeat.comSimplify Asset Management Inc. Increases Position in Royalty Pharma plc (NASDAQ:RPRX)Simplify Asset Management Inc. lifted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 67.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,066 shares of the biopharmaceutical company's stock afNovember 15, 2024 | marketbeat.comRoyalty Pharma Announces Inaugural Prize for Impact in HealthcareNovember 14, 2024 | globenewswire.comRoyalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying IssuesNovember 14, 2024 | finance.yahoo.com3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a DecadeNovember 14, 2024 | fool.comNew South Capital Management Inc. Has $69.77 Million Stake in Royalty Pharma plc (NASDAQ:RPRX)New South Capital Management Inc. increased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,466,371 shares of the biopharmaceutical company's stock aNovember 12, 2024 | marketbeat.comBaillie Gifford & Co. Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)Baillie Gifford & Co. trimmed its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,122,491 shares of the biopharmaceutical company's stock after sNovember 12, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Holdings Cut by Los Angeles Capital Management LLCLos Angeles Capital Management LLC lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 13.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 387,697 shares of the biopharmaceutical company's sNovember 12, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stock Position Lifted by Van ECK Associates CorpVan ECK Associates Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 171.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 101,500 shares of the biopharmaceutical comNovember 11, 2024 | marketbeat.comSummit Global Investments Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX)Summit Global Investments acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,991 shares of the biopharmaceuticalNovember 10, 2024 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼0.680.77▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼76▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPRX Stock Alerts